| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,326 | 6,760 | 6,826 | 6,249 | | Cost of Revenue | 1,827 | 1,935 | 1,940 | 1,765 | | | Gross Profit | 4,499 | 4,825 | 4,885 | 4,484 | | | Operating Expenses | | Research Development | 1,512 | 1,409 | 1,322 | 608 | | Selling General and Administrative | 4,912 | 5,281 | 4,853 | 3,053 | | Non Recurring |
-
|
-
|
-
| (1,587) | | Others |
-
|
-
|
-
| (350) | | | | Total Operating Expenses |
-
|
-
|
-
| 1,724 | | | | Operating Income or Loss | (1,924) | (1,864) | (1,289) | 2,760 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,339) | 64 | 73 | (170) | | Earnings Before Interest And Taxes | (9,263) | (1,801) | (1,217) | 2,589 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (9,263) | (1,801) | (1,217) | 2,589 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| (131) | | | | Net Income From Continuing Ops | (9,263) | (1,801) | (1,217) | 2,458 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (6,601) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,263) | (1,801) | (1,217) | (4,142) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,263) | ($1,801) | ($1,217) | ($4,142) |
|
0.11% Nasdaq 
0.01%
Income Statement
